The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s gastric volvulus treatment market report forecasts the gastric volvulus treatment market size to grow to $31.8 Billion by 2027, with a CAGR (compound annual growth rate) of more than 5%.

Learn More On The Gastric Volvulus Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Gastric Volvulus Treatment Market Size Forecast
The global gastric volvulus treatment market is expected to grow from $24.19 billion in 2022 to $25.73 billion in 2023 at a compound annual growth rate (CAGR) of 6.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global gastric volvulus treatment market size is expected to reach $31.8 billion in 2027 at a CAGR of 5.4%.

North America held the largest gastric volvulus treatment market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Gastric Volvulus Treatment Market Driver ­– Rise In Geriatric Population
According to the United Nations Department of Economic and Social Affairs’ September 2020 report, the population aged 65 and up is expected to increase from 9.3% in 2020 to roughly 16.0% in 2050. Furthermore, according to a World Health Organisation factsheet published in October 2021, there will be 1.4 billion people over the age of 60 in the world by 2030, up from 1 billion in 2020. As a result, the growing senior population is driving the gastric volvulus therapy market.

Request for A Sample Of The Global Gastric Volvulus Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

Key Gastric Volvulus Treatment Market Trend – Product Innovations
To maintain their market position in the gastric volvulus therapy industry, major market players are launching innovative products. For example, in December 2020, 9 Metres Biopharma, Inc., a clinical-stage firm based in the United States that focuses on rare and unmet needs in gastroenterology, will begin NM-002, a patented long-acting GLP-1, in a Phase 1b/2a trial for short bowel syndrome. NM-002 is a long-acting injectable GLP-1 receptor agonist that extends its circulation half-life using unique XTEN technology. This is specifically designed to delay digestive transit time in SBS patients by decreasing upper GI motility and treating chronic diarrhoea caused by a shorter intestine.

Gastric Volvulus Treatment Market Segment
1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus
2) By Treatment Type: Medication, Surgery
3) By Route of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Gastric Volvulus Treatment Market Major Players and Strategies
Major players in the gastric volvulus treatment market are Sawai Pharmaceutical Co Ltd, PAI Pharma, Sun Pharmaceutical Industries Ltd, ANI Pharmaceuticals Inc., Fresenius SE and Co KGaA, Mayne Pharma Group Limited, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Tris Pharma Inc., Pfizer Inc., Mallinckrodt, Mylan N.V., GlaxoSmithKline plc, Par Pharmaceutical, Vintage Labs, and Zydus Group.

Arena Pharmaceuticals was acquired for $6.7 billion by Pfizer, a US-based pharmaceutical and science business, in December 2021. This purchase will give expertise in inflammation and immunology, with a Pfizer innovation engine investigating viable treatments for patients suffering from debilitating immuno-inflammatory disorders who require more effective treatment alternatives. Arena’s is a firm established in the United States that has a varied and promising pipeline of development-stage therapeutic candidates in gastroenterology, dermatology, and cardiology, as well as gastrointestinal and dermatological illnesses.

The Gastric Volvulus Treatment Global Market Report 2023 covers regional data on gastric volvulus treatment market size, gastric volvulus treatment market trends and drivers, opportunities, strategies, and gastric volvulus treatment market competitor analysis. The countries covered in the gastric volvulus treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Surgical treatment for gastric volvulus includes volvulus reduction, reintegration of the stomach into the abdominal cavity in situations of intrathoracic migration, and correction of causative causes. Gastric volvulus surgery is often straightforward, requiring de-rotation, lowering of the hernial contents into the abdominal wall, and hernial defect correction.

View More Reports Related To The Gastric Volvulus Treatment Market –
Gastric Cancer Drugs Global Market Report 2023
Urinary Stone Treatment Devices And Equipment Global Market Report 2023
Polycystic Ovarian Syndrome Treatment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: